RET mutation p.S891A in a Chinese family with familial medullary thyroid carcinoma and associated cutaneous amyloidosis binding OSMR variant p.G513D-Reference-Cited by-同舟云学术

RET mutation p.S891A in a Chinese family with familial medullary thyroid carcinoma and associated cutaneous amyloidosis binding OSMR variant p.G513D

Published:2015-08-22 Issue:32 Volume:6 Page:33993-34003
ISSN:1949-2553
Container-title:Oncotarget
language:en
Short-container-title:Oncotarget

Author:

Qi Xiao-Ping¹,Zhao Jian-Qiang²,Chen Zhen-Guang¹,Cao Jin-Lin¹,Du Juan³,Liu Nai-Fang¹,Li Feng¹,Sheng Mao¹,Fu Er¹,Guo Jian¹⁴,Jia Hong⁵,Zhang Yi-Ming¹,Ma Ju-Ming¹

Affiliation:

1. Department of Oncologic and Urology Surgery, the 117th PLA Hospital, Wenzhou Medical University, Hangzhou 310004, Zhejiang Province, China

2. Department of Head and Neck Surgery, Zhejiang Cancer Hospital, Hangzhou 310022, Zhejiang Province, China

3. Zhejiang Academy of Medical Sciences, Hangzhou 310007, Zhejiang Province, China

4. Department of Dermatology, the 117th PLA Hospital, Wenzhou Medical University, Hangzhou 310004, Zhejiang Province, China

5. Institute of Dermatology, Chinese Academy of Medical Sciences and Peking Union Medical College, Nanjing 210042, Jiangsu Province, China

Publisher

Impact Journals, LLC

Subject

Oncology

Cited by 16 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Thyroid Malignancy and Cutaneous Lichen Amyloidosis: Key Points Amid RET Pathogenic Variants in Medullary Thyroid Cancer/Multiple Endocrine Neoplasia Type 2 (MEN2);International Journal of Molecular Sciences;2024-09-10

2. Targeting the RET tyrosine kinase in neuroblastoma: A review and application of a novel selective drug design strategy;Biochemical Pharmacology;2023-10

3. Clinic Heterogeneity and Management of Pediatric Patients With Germline RET Proto-oncogene Mutation: Single-center Experience;Journal of Pediatric Hematology/Oncology;2023-07-24

4. Overview of the 2022 WHO Classification of Familial Endocrine Tumor Syndromes;Endocrine Pathology;2022-03

5. Spectrum of Germline RET variants identified by targeted sequencing and associated Multiple Endocrine Neoplasia type 2 susceptibility in China;BMC Cancer;2021-04-07